TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $50,000 | -20.6% | 37,300 | -33.3% | 0.00% | – |
Q4 2018 | $63,000 | -59.1% | 55,900 | 0.0% | 0.00% | – |
Q3 2018 | $154,000 | -23.0% | 55,900 | 0.0% | 0.00% | – |
Q2 2018 | $200,000 | +19.0% | 55,900 | +2.4% | 0.00% | – |
Q1 2018 | $168,000 | -51.2% | 54,600 | 0.0% | 0.00% | – |
Q4 2017 | $344,000 | -7.8% | 54,600 | 0.0% | 0.00% | – |
Q3 2017 | $373,000 | -11.6% | 54,600 | -7.8% | 0.00% | – |
Q2 2017 | $422,000 | -17.1% | 59,200 | +6.9% | 0.00% | – |
Q1 2017 | $509,000 | +128.3% | 55,400 | 0.0% | 0.00% | – |
Q4 2016 | $223,000 | +5.2% | 55,400 | 0.0% | 0.00% | – |
Q3 2016 | $212,000 | -10.9% | 55,400 | 0.0% | 0.00% | – |
Q2 2016 | $238,000 | +11.7% | 55,400 | +20.3% | 0.00% | – |
Q1 2016 | $213,000 | -57.7% | 46,040 | -8.2% | 0.00% | – |
Q4 2015 | $503,000 | +27.0% | 50,140 | -5.6% | 0.00% | – |
Q3 2015 | $396,000 | -99.2% | 53,140 | -95.0% | 0.00% | -100.0% |
Q2 2015 | $50,248,000 | +30.8% | 1,059,196 | +1.0% | 0.04% | +35.5% |
Q1 2015 | $38,414,000 | -6.4% | 1,048,429 | +1.4% | 0.03% | -8.8% |
Q4 2014 | $41,055,000 | +146525.0% | 1,033,880 | +73748.6% | 0.03% | – |
Q3 2014 | $28,000 | -26.3% | 1,400 | -50.0% | 0.00% | – |
Q2 2014 | $38,000 | +1800.0% | 2,800 | +1791.9% | 0.00% | – |
Q1 2014 | $2,000 | 0.0% | 148 | 0.0% | 0.00% | – |
Q4 2013 | $2,000 | -66.7% | 148 | -73.0% | 0.00% | – |
Q3 2013 | $6,000 | +20.0% | 548 | -24.1% | 0.00% | – |
Q2 2013 | $5,000 | – | 722 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |